BTK Inhibitors in CLL: Striking a Balance Between Effectiveness and Heart Health
BTK Inhibitors in CLL: Striking a Balance Between Effectiveness and Heart Health
Overview
An engaging three-part podcast series designed to empower oncology/cardiology nurses and advanced practice providers with the knowledge and practical tools needed to support patients with chronic lymphocytic leukemia (CLL) undergoing treatment with BTK inhibitors. Each episode brings clinical insights and evidence-based strategies to the forefront, helping nurses navigate the complexities of the BTK inhibitor therapy from both a pharmacological and patient-care perspective.
Accreditation Type
- Physicians—maximum of 1.0 AMA PRA Category 1 Credit(s)™
- Nurses—1.0 contact hours of nursing continuing professional development credit
- PAs—maximum of 1.0 AAPA Category 1 CME credits
Estimated Time to Complete Activity:
1 hour
Learning Objectives
Upon completion of this course, you should be able to:
- Differentiate between the clinical profiles of various BTK inhibitors used in CLL treatment, including long-term data
- Identify and compare the CV risk profiles associated with different BTK inhibitors in CLL therapy
- Develop comprehensive management plans to prevent, mitigate, and manage CV complications in patients with CLL treated with BTK inhibitors, while incorporating recent clinical data and updated guidelines
- Incorporate patient perspectives and multidisciplinary approaches into treatment decisions and long-term management in patients with CLL
Faculty
Anecita Fadol, PhD, APRN, FNP, FAANP, FHKAN (Hon.), FAAN
Department of Nursing, Division of SrVP and Chief Nursing Officer
MD Anderson Cancer Center
Houston, TX
Amy Goodrich, RN, BSN, MSN, CRNP-AC
Research Associate, Nurse Practitioner
Johns Hopkins Kimmel Cancer Center
Baltimore, MD
Lisa Nodzon, PhD, APRN, AOCNP
Advanced Registered Nurse Practitioner, APP Lead
Moffitt Cancer Center
Tampa, FL
Hasana O’Neal, MHS, PA-C
Cardiology Physician Assistant
MD Anderson Cancer Center
Houston, TX
Audio Lessons
Part I
Listen On:
Part II
Listen On:
Part III
Listen On:
Additional Resources
Office Poster
Rapid Recap
FAQs
Instructions for Participation and Requesting Credit
There are no fees for participating and receiving credit for this activity. Successful completion is achieved by reviewing the CE information, completing the pre-test, completing the activity, and completing the post-test and evaluation form. A score of at least 50% on the post-test is required to successfully complete this activity. The participant may take the test until successfully passed.
Credit Fulfillment
If you are requesting AMA credits, ANCC credits, AAPA credits, or a certificate of participation, your certificate will be available for download.
Technical Requirements
- This site and its activities are best viewed using the latest versions of the Chrome, Edge, Firefox, and Safari browsers.
- Additionally, this site and its activities are best viewed using the latest operating system for your device.
Accreditation
This activity is jointly provided by The France Foundation and the International Cardio-Oncology Society.
In support of improving patient care, this activity has been planned and implemented by The France Foundation and the International Cardio-Oncology Society. The France Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Physician Credit Designation
The France Foundation designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)â„¢. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
The France Foundation designates this activity for 1.0 contact hour.
Physician Assistants
The France Foundation has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0AAPA Category 1 CME credit. Approval is valid until 6/29/26. PAs should only claim credit commensurate with the extent of their participation.
If you have questions about this CME activity, please contact The France Foundation at 860-434-1650 or [email protected].
This activity is supported by independent medical educational grants from AstraZeneca and Lilly.
Disclaimer
The France Foundation and the International Cardio-Oncology Society present this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation, the International Cardio-Oncology Society, and the commercial supporters assume no liability for the information herein.
